Life Sciences R&D Tax Credits: What Qualifies and Where Are Companies Leaving Value on the Table?

In the first episode of the Healthcare & Life Sciences Podcast, hosts Adam Hunter, Assurance Services Partner, and Carolyn Smith Driscoll, Tax Credits & Incentives Advisory, will explore the many ways research and development (R&D) tax credits impact the life sciences.

Together, they discuss what qualifies as R&D, where organizations commonly miss opportunities, and how proper documentation can help maximize credits while reducing audit risk.

Tune in to learn more about:

  • Understanding the fundamentals of R&D tax credits for life sciences companies.
  • Identifying qualifying activities across pharmaceuticals, biotech, medical devices, and diagnostics.
  • Navigating clinical trial and research-related credit opportunities.
  • Recognizing often-overlooked opportunities in process development and manufacturing scale-up.
  • Strengthening documentation to support claims and prepare for potential audits.  

Connect With Us


View All Healthcare & Life Science Podcasts

 

Carolyn Smith Driscoll Headshot

Carolyn Smith Driscoll

Tax Credits & Incentives Advisory

Director, Cherry Bekaert Advisory LLC

Adam Hunter Headshot

Adam Hunter

Assurance Services

Partner, Cherry Bekaert LLP
Partner, Cherry Bekaert Advisory LLC

Past Episodes

Podcast Healthcare and Life Science

Podcast

October 9, 2026

7:51

Speakers: Adam Hunter, Carolyn Smith Driscoll

Learn how Form 6765 changes affect life sciences R&D tax credits, including new reporting requirements, documentation and compliance strategies.

Technology Podcast thumbnail

Podcast

October 6, 2026

13:07

Speakers: Daniel Wheadon, Vivian Kohrs

Learn how Section 174 changes, Form 6765 updates and documentation requirements are shaping R&D tax credit compliance for technology companies.